Daily Report for 10/30/2026
Governor's Actions
No legislation is Signed by Governor Today
New Legislation Introduced
| Bill | Current Status | Sponsor | Synopsis | Title |
|---|---|---|---|---|
| SB 361 | Committee | Seigfried | This Act restructures the State Employee Benefits Committee into the State Employee Benefits Council and establishes 3 specialized working committees to assist the Council in managing contracted health services for State employees and eligible pensioners: the Clinical Evaluation Working Committee, the Policy and Planning Working Committee, and the Financial Evaluation Working Committee. This Act outlines the composition and statutory duties of each working committee to increase transparency, reduce costs, and improve the value of the State's health-care insurance plan. It grants all working committees the shared authority to establish quality metrics, enter into confidentiality agreements with pharmacy benefits managers, and request audits to determine the actual cost of pharmaceuticals to the State. Additionally, the Clinical Evaluation Working Committee is tasked with drafting health service agreements and managing the formulary. The Policy and Planning Working Committee is responsible for creating financial models using reference based pricing from Medicare reimbursement rates as a benchmark and requiring comprehensive financial disclosures from pharmacy benefits managers. The Financial Evaluation Working Committee is established to assess the financial implications of health policy and advise the Council. Finally, this Act mandates strict independence requirements for individuals or entities contracted to perform audits or reviews, establishes statutory definitions for key pharmacy pricing terms, and eliminates the Retiree Healthcare Benefits Advisory Subcommittee. This Act is effective January 1, 2028. | AN ACT TO AMEND TITLE 29 OF THE DELAWARE CODE RELATING TO THE STATE EMPLOYEE BENEFITS COMMITTEE. |
| SB 362 | Committee | Seigfried | This Act establishes a statewide registry for Parkinson's disease and Parkinsonisms under the regulatory oversight of the Department of Health and Social Services, with operational responsibilities delegated to a partnership between the University of Delaware and the Delaware Health Information Network. To minimize administrative burdens on providers and leverage existing infrastructure, the Act mandates that healthcare practitioners, facilities, and clinical laboratories report occurrences of these conditions within 180 days of initial diagnosis or treatment. Furthermore, the legislation establishes strict data confidentiality protections, authorizes the sharing of de-identified data for qualified scientific research, requires an annual report to the General Assembly beginning January 1, 2029, and provides an enforcement mechanism through the Department for persistent noncompliance, which is a fine of $100 per day for each violation. | AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO A PARKINSON'S DISEASE REGISTRY. |
Legislation Passed By Senate
No Legislation Passed By Senate
Legislation Passed By House of Representatives
No Legislation Passed By House
Senate Committee Assignments
| Committee |
|---|
| Executive |
House Committee Assignments
No House Committee Assignments
Senate Committee Report
No Senate Committee Report
House Committee Report
No House Committee Report
Senate Defeated Legislation
No Senate Defeated Legislation
House Defeated Legislation
No House Defeated Legislation
Nominations Enacted upon by the Senate
No Records